The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
BRCA1, BRCA2 and TP53 mutations in very early-onset breast cancer with associated risks to relatives
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Antoniou, A., Pharoah, P. D. P., Narod, S., Risch, H. A., Eyfjord, J. E., Hopper, J. L., Loman, N., Olsson, H., Johannsson, O., Borg, Å., et al. (2003) · The American Journal of Human Genetics · doi:10.1086/375033 · Cited by 3,680
Self-citationPrediction of pathogenic mutations in patients with early-onset breast cancer by family history
Lalloo, F., Varley, J., Ellis, D., Moran, A., O'Dair, L., Pharoah, P., & Evans, D. G. R. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12856-5 · Cited by 202
Self-citation
Research works printed but not linked: 24
- Ford, 1998, Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families, Am J Hum Genet, 62, 676, 10.1086/301749 · DOI · Paper page
- Li, 1982, Prospective study of a cancer family syndrome, JAMA, 247, 2692, 10.1001/jama.1982.03320440040031 · DOI · Paper page
- Gayther, 1998, The genetics of inherited breast cancer, J Mamm Gland Biol Neopasia, 3, 365, 10.1023/A:1018779830743 · DOI
- Varley, 1997, Germ-line mutations of TP53 in Li–Fraumeni families: an extended study of 39 families, Cancer Res, 14, 865
- Fitzgerald, 1996, Germ-line BRCA1 mutations in jewish and non-jewish women with early-onset breast cancer, N Engl J Med, 334, 143, 10.1056/NEJM199601183340302 · DOI · Paper page
- Peto, 1999, Prevalence of BRCA1 and BRCA2 gene mutations in patients with early onset breast cancer, J Natl Cancer Inst, 91, 943, 10.1093/jnci/91.11.943 · DOI · Paper page
- Loman, 2001, Family history of breast and ovarian cancers and BRCA1 and BRCA2 mutations in a population-based series of early onset breast cancer, J Natl Cancer Inst, 93, 1215, 10.1093/jnci/93.16.1215 · DOI
- Krainer, 1997, Differential contributions of BRCA1 and BRCA2 to early onset breast cancer, N Engl J Med, 336, 1416, 10.1056/NEJM199705153362003 · DOI · Paper page
- Sidransky, 1992, Inherited p53 gene mutations in breast cancer, Cancer Res, 52, 2984
- van Der Luijt, 1994, Rapid detection of translation-terminating mutations at the adenomatous polyposis coli (APC) gene by direct protein truncation test, Genomics, 20, 1u, 10.1006/geno.1994.1119 · DOI · Paper page
- Orita, 1989, Detection of polymorphisms of human DNA by gel electrophoresis as single-strand conformation polymorphisms, Proc Natl Acad Sci USA, 86, 2766, 10.1073/pnas.86.8.2766 · DOI · Paper page
- Ellis, 2000, Low prevalence of germline BRCA1 mutations in early onset sporadic breast cancer, J Med Genet, 37, 792, 10.1136/jmg.37.10.792 · DOI
- Rowley, 1995, Ultrarapid mutation detection by muliplex, solidphase chemical cleavage, Genomics, 30, 574, 10.1006/geno.1995.1279 · doi:10.1006/geno.1995.1279
- Lange, 1988, Programs for Pedigree Analysis: MENDEL, FISHER, and dGENE, Genet Epidemiol, 5, 471, 10.1002/gepi.1370050611 · DOI · Paper page
- de Sanjose, 2003, Prevalence of BRCA1 and BRCA2 germline mutations in young breast cancer patients: a population-based study, Int J Cancer, 106, 588, 10.1002/ijc.11271 · DOI
- Easton, 1993, Breast cancer linkage consortium. Genetic linkage analysis in familial breast and ovarian cancer: results from 214 families, Am J Hum Genet, 52, 678
- Narod, 1995, An evaluation of genetic heterogeneity in 145 breast–ovarian cancer families, Am J Hum Genet, 56, 254
- Börresen, 1992, Screening for germline TP53 mutations in breast cancer patients, Cancer Res, 52, 3234
- Sedlacek, 1998, Two Li–Fraumeni syndrome families with novel germline p53 mutations: loss of the wild-type p53 allele in only 50% of tumours, Br J Cancer, 77, 1034, 10.1038/bjc.1998.172 · DOI
- Chompret, 2000, P53 germline mutations in childhood cancers and cancer risk for carrier individuals, Br J Cancer, 82, 1932
- Anglian Breast Cancer Study Group, 2000, Prevalence and penetrance of BRCA1 and BRCA2 in a population based series of breast cancer cases, Br J Cancer, 83, 1301, 10.1054/bjoc.2000.1407 · DOI · Paper page
- Hopper, 1999, Population based estimate of the average age-specific cumulative risk of breast cancer for a defined set of protein-truncating mutations in BRCA1 and BRCA2. Australian Breast Cancer Family Study, Cancer Epidemiol Biomarkers Prev, 8, 741
- Li, 1988, A cancer family syndrome in twenty-four kindreds, Cancer Res, 48, 5358
- Birch, 1994, Prevalence and diversity of constitutional mutations in the p53 gene among 21 Li–Fraumeni families, Cancer Res, 54, 1298
Cited by
TP53 mutations in human cancers: origins, consequences, and clinical use.
Olivier, M., Hollstein, M., & Hainaut, P. (2010) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a001008 · Cited by 2,199
Cancer statistics for adolescents and young adults, 2020
Miller, K. D., Fidler‐Benaoudia, M., Keegan, T. H., Hipp, H. S., Jemal, A., & Siegel, R. L. (2020) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21637 · Cited by 1,190
TP53 mutations in human cancers: Functional selection and impact on cancer prognosis and outcomes
Petitjean, A., Achatz, M. I. W., Borresen-Dale, A. L., Hainaut, P., & Olivier, M. (2007) · Oncogene · doi:10.1038/sj.onc.1210302 · Cited by 884
Revisiting Li-Fraumeni Syndrome From TP53 Mutation Carriers
Bougeard, G., Renaux-Petel, M., Flaman, J.-M., Charbonnier, C., Fermey, P., Belotti, M., Gauthier-Villars, M., Stoppa-Lyonnet, D., Consolino, E., Brugières, L., et al. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2014.59.5728 · Cited by 760
Cancer Screening Recommendations for Individuals with Li-Fraumeni Syndrome
Kratz, C. P., Achatz, M. I., Brugières, L., Frebourg, T., Garber, J. E., Greer, M.-L. C., Hansford, J. R., Janeway, K. A., Kohlmann, W. K., McGee, R., et al. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-0408 · Cited by 534
Self-citation
Metadata
- Authors
- Lalloo, F., Varley, J., Moran, A., Ellis, D., O’Dair, L., Pharoah, P., Antoniou, A., Hartley, R., Shenton, A., Seal, S., Bulman, B., Howell, A., & Evans, D. G. R.
- Venue
- European Journal of Cancer
- Publisher
- Elsevier BV
- Published
- 2006-05
- Volume
- 42
- Issue
- 8
- Pages
- 1143-1150
- ISSN
- 0959-8049 (ISSN-L)
- OpenAlex
- W1999479708
- Cited by
- 175
- References
- 2
- FWCI
- 4.77
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.